Pharmaceutical Products Supplementary 002
Tender Overview
About this tender
Overview HealthShare Victoria has released an update to Pharmaceutical Products Supplementary 002, covering the supply of specified pharmaceutical products. Scope The scope for Supplementary 002 includes the following subcategories: 34.01: Apixaban 2.5 mg tablet, 20 34.02: Apixaban 2.5 mg tablet, 30 34.03: Apixaban 2.5 mg tablet, 60 34.04: Apixaban 5 mg tablet, 28 34.05: Apixaban 5 mg tablet, 60 Tender Briefing Supplier Briefing Date: 13 August 2026 (tentative) Contract Terms and Conditions Contract Commencement Date: 19 October 2026 (tentative) Instructions to Tenderers The following tentative dates apply to this procurement: Market Release Date: 14 August 2026 Market Closing Date: 24 August 2026, 2:00 pm AEST For further details, please refer to the HSV website and HSV procurement portal: https://healthsharevic.org.au Enquiries Contact: Ha Nguyen Office: +61 (03) 9124 1949 Email: h.nguyen@healthsharevic.org.au
How to respond to this tender
A strong tender response is clear, compliant, and backed by evidence. These steps apply to most Australian and New Zealand public tenders.
Read the requirements in full
Open the official listing and download the full tender pack. Note the response schedules, evaluation criteria, mandatory conditions, and the exact closing time and lodgement method.
Confirm you are eligible and it is worth bidding
Check licences, insurances, certifications, and any conformance requirements before you commit. A quick bid or no-bid decision saves days of wasted effort on a tender you cannot win.
Answer every criterion with evidence
Respond to each evaluation criterion directly and back your claims with concrete examples, referees, and past performance. Address the buyer’s stated need, not a generic capability statement.
Lodge early through the official portal
Submit through the source portal well before the deadline. Late or incorrectly lodged bids are almost always rejected, so leave time for uploads, portal errors, and last-minute questions.
